BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34783177)

  • 1. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and
    Thompson SM; Suman G; Torbenson MS; Chen ZE; Jondal DE; Patra A; Ehman EC; Andrews JC; Fleming CJ; Welch BT; Kurup AN; Roberts LR; Watt KD; Truty MJ; Cleary SP; Smoot RL; Heimbach JK; Tran NH; Mahipal A; Yin J; Zemla T; Wang C; Fogarty Z; Jacobson M; Kemp BJ; Venkatesh SK; Johnson GB; Woodrum DA; Goenka AH
    Hepatol Commun; 2022 May; 6(5):1172-1185. PubMed ID: 34783177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis.
    Chen LX; Zou SJ; Li D; Zhou JY; Cheng ZT; Zhao J; Zhu YL; Kuang D; Zhu XH
    World J Gastroenterol; 2020 Dec; 26(48):7664-7678. PubMed ID: 33505143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of
    Shamim SA; Kumar N; Arora G; Jaswal S; Shalimar ; Gamanagatti S; Bal C
    Ann Nucl Med; 2024 Feb; 38(2):103-111. PubMed ID: 37926772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
    Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Kunikowska J; Cieślak B; Gierej B; Patkowski W; Kraj L; Kotulski M; Zieniewicz K; Królicki L
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):883-892. PubMed ID: 32885272
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hirmas N; Leyh C; Sraieb M; Barbato F; Schaarschmidt BM; Umutlu L; Nader M; Wedemeyer H; Ferdinandus J; Rischpler C; Herrmann K; Costa PF; Lange CM; Weber M; Fendler WP
    J Nucl Med; 2021 Sep; 62(9):1235-1241. PubMed ID: 33509970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT.
    Kuyumcu S; Has-Simsek D; Iliaz R; Sanli Y; Buyukkaya F; Akyuz F; Turkmen C
    Clin Nucl Med; 2019 Sep; 44(9):702-706. PubMed ID: 31348076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of PET imaging of activated fibroblasts and
    Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT.
    Kang C; Jiang JY; Lee ME; Shen L; Mansberg R
    Clin Nucl Med; 2022 Mar; 47(3):e291-e293. PubMed ID: 35020661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
    van Lith SAM; Pruis IJ; Tolboom N; Snijders TJ; Henssen D; Ter Laan M; Te Dorsthorst M; Leenders WPJ; Gotthardt M; Nagarajah J; Robe PA; De Witt Hamer P; Hendrikse H; Oprea-Lager DE; Yaqub M; Boellaard R; Wesseling P; Balvers RK; Verburg FA; Harteveld AA; Smits M; van den Bent M; van Zanten SEMV; van de Giessen E
    J Nucl Med; 2023 Oct; 64(10):1526-1531. PubMed ID: 37652540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of
    Hofman MS; Eu P; Jackson P; Hong E; Binns D; Iravani A; Murphy D; Mitchell C; Siva S; Hicks RJ; Young JD; Blower PJ; Mullen GE
    J Nucl Med; 2018 Apr; 59(4):625-631. PubMed ID: 28986512
    [No Abstract]   [Full Text] [Related]  

  • 15.
    van Boxtel W; Lütje S; van Engen-van Grunsven ICH; Verhaegh GW; Schalken JA; Jonker MA; Nagarajah J; Gotthardt M; van Herpen CML
    Theranostics; 2020; 10(5):2273-2283. PubMed ID: 32089741
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity of [
    Pan J; Zhao J; Ni X; Zhu B; Hu X; Wang Q; Wei Y; Zhang T; Gan H; Wang B; Wu J; Song S; Liu C; Ye D; Zhu Y
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1822-1832. PubMed ID: 36719427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
    Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
    Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
    Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
    J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer.
    Al Jalali V; Wasinger G; Rasul S; Grubmüller B; Wulkersdorfer B; Balber T; Mitterhauser M; Simon J; Hacker M; Shariat S; Egger G; Zeitlinger M
    J Nucl Med; 2023 Jun; 64(6):863-868. PubMed ID: 36657982
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
    J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.